ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 187,65
0,69%
Dow Jones
39 387,76
0,85%
DAX
18 686,60
1,07%
Brent Oil
84,135
0,22%
Bitcoin
62 871,77
-0,28%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Puma Biotechnology Inc (PBYI)

  7. Puma Biotechnology Inc (PBYI) Actualités

PBYI Puma Biotechnology Inc

4,79
-0,04 (-0,83%)
09 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Puma Biotechnology Inc PBYI NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,04 -0,83% 4,79 23:59:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
4,83 4,75 4,93 4,79 4,83
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/5/202422:05BWPuma Biotechnology Reports First Quarter Financial Results
18/4/202422:15BWPuma Biotechnology to Host Conference Call to Discuss First..
03/4/202423:30BWPuma Biotechnology Reports Inducement Awards Under Nasdaq..
20/3/202413:30BWPuma Biotechnology Announces FDA Allowance to Proceed Under..
29/2/202422:16EDGAR2Form 8-K - Current report
29/2/202422:05BWPuma Biotechnology Reports Fourth Quarter and Full Year 2023..
28/2/202400:30BWPuma Biotechnology Reports Inducement Awards Under Nasdaq..
22/2/202422:10BWPuma Biotechnology to Participate in a Panel Discussion at..
15/2/202422:10BWPuma Biotechnology to Host Conference Call to Discuss Fourth..
15/2/202400:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202423:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202414:19EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202414:30BWPuma Biotechnology Announces Initiation of ALISCA-Lung1..
06/2/202421:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
18/1/202415:00EDGAR2Form 8-K - Current report
11/1/202422:07BWPuma Biotechnology to Present at B. Riley Securities 4th..
10/1/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202422:38EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
06/1/202401:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202400:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202400:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202403:40EDGAR2Form 144 - Report of proposed sale of securities
04/1/202403:39EDGAR2Form 144 - Report of proposed sale of securities
04/1/202403:35EDGAR2Form 144 - Report of proposed sale of securities
04/1/202403:34EDGAR2Form 144 - Report of proposed sale of securities
11/12/202314:30BWPuma Biotechnology Announces Phase II Clinical Trial Design..
06/11/202323:15BWPuma Biotechnology Reports Inducement Awards Under Nasdaq..
02/11/202321:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202321:19EDGAR2Form 8-K - Current report
02/11/202321:05BWPuma Biotechnology Reports Third Quarter 2023 Financial..
19/10/202322:14BWPuma Biotechnology to Host Conference Call to Discuss Third..
14/10/202318:30BWPuma Biotechnology Announces Presentation of Findings from a..
04/10/202323:30BWPuma Biotechnology Reports Inducement Awards Under Nasdaq..
26/9/202322:10EDGAR2Form 8-K - Current report
21/9/202323:02DJNPuma Biotechnology Stock Up 6.9% on New FDA Orphan Drug..
21/9/202322:55DJNPuma Biotechnology Gets Orphan Designation for Small Cell..
21/9/202322:10BWPuma Biotechnology Receives FDA Orphan Drug Designation for..
01/9/202316:18EDGAR2Form SC 13G - Statement of acquisition of beneficial..
31/8/202322:07BWPuma Biotechnology to Present at the H.C. Wainwright 25th..
18/8/202322:17EDGAR2Form 8-K - Current report
08/8/202314:30BWPuma Biotechnology Announces FDA Clearance of IND for..
03/8/202322:41EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202322:12EDGAR2Form 8-K - Current report
03/8/202322:05BWPuma Biotechnology Reports Second Quarter Financial Results
20/7/202322:15BWPuma Biotechnology to Host Conference Call to Discuss Second..
07/7/202301:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/7/202301:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
PBYI
Puma Biotechnology
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés